Advertisement
Advertisement

MLTX

MLTX logo

MoonLake Immunotherapeutics Class A Ordinary Shares

18.41
USD
Sponsored
+0.22
+1.21%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

18.68

+0.27
+1.49%

MoonLake Immunotherapeutics Class A Ordinary Shares Profile

About

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

Info & Links

CEO

Jorge Santos da Silva

Headquarters

DORFSTRASSE 29
ZUG, V8 6300, SWITZERLAND

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.moonlaketx.com

Auditor

Baker Tilly US, LLP

Share holders

7

Employees

130

MoonLake Immunotherapeutics Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

1.38B

Enterprise Value

1.18B

Enterprise Value/EBITDA(ttm)

-4.45

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-66.56%

Return on Invested Capital(ttm)

-57.36%

Return on Assets(ttm)

-50.23%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-264.29M

Net Income Available to Common(ttm)

-257.08M

Diluted EPS(ttm)

-3.52

Share Statistics

Beta (5Y Monthly)

1.19

52-Week Change

-52.23%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

73.62M

Dividend Yield

0.00%

Float4

63.11M

% Held by Insiders

12.02%

% Held by Institutions

93.85%

Balance Sheet

Total Cash(mrq)

357.92M

Total Cash Per Share(mrq)

4.86

Total Debt(mrq)

99.02M

Total Debt/Equity(mrq)

24.34%

Current Ratio(mrq)

9.27%

Quick Ratio(mrq)

9.27%

Book Value Per Share(mrq)

4.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.04

Free Cash Flow(ytd)

-196.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement